These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 يونيو. The technology gains life-saving medical insights by analysing human excrement. قدمت الشركة سلسلة من ثلاث براءات اختراع تغطي عناصر مستشعر المرحاض الطبي الخاص بها.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, أوروبا, اليابان والصين.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, يمكن لتقنية OutSense تحديد مصدر الدم على طول الجهاز الهضمي.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

وفقًا للرئيس التنفيذي لشركة OutSense Yfat Scialom, who predicts that “مع انفجار الطب الرقمي, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, مرض التهاب الأمعاء والتهابات المسالك البولية.

Its solution consists of a multispectral optical sensor, مصدر ضوء وجهاز فحص مستقل يتضمن اتصال WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. المعلومات التي تم الحصول عليها من عينات الدم, جنبا إلى جنب مع تحليل إضافي للوقت من النزيف إلى الإفراز, يقدم تفاصيل عن أمراض النزيف. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, أعلنت شركة OutSense أن CommuniCare, شركة رعاية صحية كبيرة تضم أكثر من 90 healthcare facilities in the US, ستبدأ بتجريب تقنيتها هذا العام. بالإضافة إلى هذا الطيار, OutSense also plans to conduct clinical trials in Israel and Japan.

قم بزيارة المزيد من الأخبار على أخبار Viga.cc